A $77 million building permit was signed off Thursday for another expansion phase at Eli Lilly’s Concord manufacturing campus, a clear signal the drugmaker is still going big at The Grounds at Concord. The permit covers interior upgrades and equipment installations inside an existing building that will support injectable production and packaging operations. Local contractors have been steadily handling a string of upfits across the site as the company scales up manufacturing.
As reported by the Charlotte Business Journal, the filing is valued at roughly $77 million and is tied to work inside an existing Lilly facility described as a new manufacturing line for injectable products. The Business Journal notes local contractors involved in the project and connects this latest permit to broader construction activity on the campus, underscoring that the Concord site remains in an active buildout phase.
According to permit data from Construction Monitor, multiple large commercial permits were pulled in 2024 for 1420 Concord Parkway South, each with values around $38.23 million. Taken together, those numbers roughly line up with the $77 million total. The aggregated filings list Eli Lilly and BE&K Building Group on the paperwork and indicate major interior work and equipment installations rather than new ground-up buildings.
Permit listings from BuildZoom show that local firm McFarland Construction is handling several interior upfits at the campus this year, including pack-line equipment installation and gowning-vestibule work. BuildZoom lists multiple trade permits at 1420 Concord Parkway South describing packaging-line rigging, electrical work and clean-room-related alterations. Those entries point to McFarland and other local contractors executing the packaging and equipment work that ties into the larger permit filings.
How This Fits Into Lilly’s Buildout
The $77 million filing marks another step in a multi-year buildout at The Grounds at Concord. Eli Lilly officially opened its Concord manufacturing campus in June 2024, according to the Charlotte Business Journal. The project’s initial announcement in 2022, which outlined roughly a $1 billion investment and an expected 589 jobs, was covered by local outlets including WSOC-TV.
What The Permits Show
Permit descriptions and contractor filings point to equipment installation, clean-room modifications and packaging-line work rather than fresh ground-up construction. That tracks with typical pharma scale-ups, where companies retrofit existing buildings to add sterile manufacturing lines and boost packaging capacity. Municipal permit listings show multiple mechanical, electrical and plumbing trade permits tied to the campus, suggesting the bulk of the current activity is internal buildout work.
For Concord and Cabarrus County, the latest permit is another data point in a steady run of industrial investment at The Grounds at Concord and could translate into more equipment deliveries, contractor crews and subcontracting work on site in the coming months. This story will be updated if county records or Eli Lilly release additional details about timing or about the specific products that will come off the new line.
